1. Home
  2. Bills
  3. S. 5265

S. 5265 · 119th Congress · 2025–2026

USTRx Act

S. 5265 in the 119th Congress (2025–2026) was introduced on Aug 5, 2026, sponsored by Tim Sheehy with 2 co-sponsors.

During the 119th Congress (2025–2026), Donald Trump was president, and Republicans held majorities in both the House and Senate.

Status
Introduced
Introduced
Aug 5, 2026
Co-sponsors
2
Policy area
Foreign Trade and International Finance

What it does

Use Sovereignty To reduce Rx Act or the USTRx Act This bill establishes the role of Chief Pharmaceutical Trade Negotiator within the Office of the U.S. Trade Representative (USTR). The negotiator must conduct trade negotiations, enforce trade agreements relating to U.S. pharmaceutical products, and address acts, policies, or practices of high-income countries that adversely impact the market access of U.S.

Summary by the nonpartisan Congressional Research Service.

Sponsor

Tim Sheehy (R-MT). Co-sponsors: 2 Republicans.

Where it stands

  • IntroducedAug 5, 2026
  • Passed the Senate—
  • Passed the House—
  • Sent to the President—
  • Became law—

Latest action: Read twice and referred to the Committee on Finance. (Aug 5, 2026)

More bills from Tim Sheehy in the 119th Congress

Other Foreign Trade and International Finance bills in the 119th Congress

Committees

More

From GovInfo bill records, Congressional Research Service summaries, Voteview roll calls and lobbying reports.

Cite or embed this page

Capitol Receipts, “S. 5265 (119th Congress): USTRx Act,” https://www.capitolreceipts.com/bill/119-s-5265/ustrx-act (accessed 2026-10-13).